Cargando…

The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model

Erectile dysfunction is a common side effect of finasteride and dutasteride treatments. The objective of this study was to investigate the structural changes in the penis using a benign prostatic hyperplasia (BPH) rodent model treated with dutasteride or finasteride. Sixty male rats were divided int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Silva, Marcello H A, Costa, Waldemar S, Sampaio, Francisco J B, De Souza, Diogo B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116690/ https://www.ncbi.nlm.nih.gov/pubmed/29893293 http://dx.doi.org/10.4103/aja.aja_28_18

Ejemplares similares

Histomorphometric comparison of the corpus cavernosum of rats submitted to euthanasia with ketamine and xylazine or isoflurane
por: Procópio, Isabella Mendes, et al.
Publicado: (2021)

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016)

The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis
por: Li, Yao, et al.
Publicado: (2022)

Effects of dutasteride and tamsulosin on penile morphology in a rodent model
por: Da Silva, Marcello H. A., et al.
Publicado: (2023)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study
por: da Silva, Marcello Henrique Araújo, et al.
Publicado: (2021)

Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials
por: Zhou, Zhongbao, et al.
Publicado: (2020)

How to Quantify Penile Corpus Cavernosum Structures with Histomorphometry: Comparison of Two Methods
por: Felix-Patrício, Bruno, et al.
Publicado: (2015)

The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010)

Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
por: Smith, Angela B, et al.
Publicado: (2009)

Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States
por: DerSarkissian, Maral, et al.
Publicado: (2016)

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
por: Khedmati, Jamaleddin, et al.
Publicado: (2021)

Frozen-Thawed Sperm Analysis of Benign Prostatic Hyperplasia Dogs Treated With Finasteride
por: Flores, Renato Bueno, et al.
Publicado: (2022)

The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
por: Sullivan, Michael J, et al.
Publicado: (2002)

Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs
por: Angrimani, Daniel S. R., et al.
Publicado: (2020)

Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia
por: Thomson, Andrew
Publicado: (2005)

The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2012)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
por: Shin, Yu Seob, et al.
Publicado: (2019)

Alteration of Gut Microbes in Benign Prostatic Hyperplasia Model and Finasteride Treatment Model
por: An, Jinho, et al.
Publicado: (2023)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)

Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
por: Sirufo, Maria Maddalena, et al.
Publicado: (2021)

Partial thrombosis of the corpus cavernosum
por: Autran, Tatiana Bagrichevsky, et al.
Publicado: (2018)

Cases of Induration in the Corpus-Cavernosum
por: Miller, H. V. M.
Publicado: (1867)

Finasteride in the treatment of clinical benign prostatic hyperplasia: A systematic review of randomised trials
por: Edwards, Jayne E, et al.
Publicado: (2002)

Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?
por: Angrimani, Daniel S. R., et al.
Publicado: (2020)

Partial segmental thrombosis of the corpus cavernosum
por: Głuchowski, Jarosław, et al.
Publicado: (2011)

The Effect of Alcohol Administration on the Corpus Cavernosum
por: Choi, See Min, et al.
Publicado: (2017)

Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus
por: Elkelany, Osama O, et al.
Publicado: (2015)

Short-term Effect of Tamsulosin and Finasteride Monotherapy and their Combination on Nigerian Men with Benign Prostatic Hyperplasia
por: Odusanya, Benjamin O, et al.
Publicado: (2017)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
por: Kiguradze, Tina, et al.
Publicado: (2017)

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
por: Traish, Abdulmaged M.
Publicado: (2020)

Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
por: Barkin, Jack
Publicado: (2011)

Changes in Sexual Function in Benign Prostatic Hyperplasia Patients Taking Dutasteride: 1-Year Follow-Up Results
por: Chi, Byung Hoon, et al.
Publicado: (2011)

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin
por: Djavan, Bob, et al.
Publicado: (2011)

Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model
por: Choi, Bo Ram, et al.
Publicado: (2018)

Case Series of Lipid Accumulation in the Human Corpus Cavernosum
por: Alwaal, Amjad, et al.
Publicado: (2015)

Total Penectomy for Recurrent Chordoma of the Corpus Cavernosum
por: Eismann, Lennert, et al.
Publicado: (2020)

Corpus cavernosum abscess: A case report
por: Kyoshi Hidaka, Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jl3nm0ev4g9d9qo50lhvnfc5al